Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al
[DOI] [PubMed] [Google Scholar] 66.Vasileva L.V., Savova M.S., Amirova K.M., Balcheva-Sivenova Z., Ferrante C., Orlando G., Wabitsch M., Georgiev M.I
A standard IV glutathione push at Instadrip delivers 1000mg or 2000mg
Given that NACA was able to counteract the effects of the ACOX1 gain-of-function mutation, antioxidant treatment was considered for patient#1 during a severe disease flare
Further studies are needed to clarify optimal dose and delivery forms and one mandatory target should be the identification of sub-groups of individuals most likely to respond to particular supplements, nutrients or foods